Morphic Holding — Shares surged more than 75% on news that Eli Lilly will acquire the biopharma company in a $3.2 billion deal .
The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease.
Eli Lilly shares inched up 0.2% on the news.
SolarEdge — The energy company rose 5% after Bank of America upgraded shares to neutral from underperform, citing an attractive entry point for investors.
Gilead — Shares of the biotech stock rose more than 2% after an upgrade to outperform from market perform at Raymond James.
Persons:
Eli Lilly, SolarEdge, Guggenheim, ServiceNow, John DiFucci, Baird, Gilead —, Raymond James, Gilead, Sarah Min, Jesse Pound, Michelle Fox, Yun Li
Organizations:
Paramount, Skydance Media, Bank of America, PNC, UBS, KeyCorp, Columbia, —